ValuEngine Downgrades NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) to Sell

ValuEngine cut shares of NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) from a hold rating to a sell rating in a research note released on Friday, September 1st.

Separately, Roth Capital reiterated a buy rating and issued a $5.50 target price on shares of NovaBay Pharmaceuticals in a research note on Monday, June 5th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. NovaBay Pharmaceuticals has a consensus rating of Hold and an average target price of $7.17.

NovaBay Pharmaceuticals (NYSEMKT NBY) opened at 4.35 on Friday. The company has a 50-day moving average of $4.42 and a 200 day moving average of $3.70. The firm’s market cap is $66.59 million. NovaBay Pharmaceuticals has a 52-week low of $2.25 and a 52-week high of $5.09.

WARNING: This piece of content was originally posted by BBNS and is the sole property of of BBNS. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://baseballnewssource.com/markets/novabay-pharmaceuticals-inc-nby-downgraded-to-sell-at-valuengine/1571071.html.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc, formerly NovaCal Pharmaceuticals, Inc, is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for NovaBay Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Dodgers End Losing Streak at 11 Behind Ace Clayton Kershaw
Dodgers End Losing Streak at 11 Behind Ace Clayton Kershaw
Cleveland Indians Winning Streak Reaches 18
Cleveland Indians Winning Streak Reaches 18


Leave a Reply

 
© 2006-2017 BBNS.